FindTrial
Sign In

A Study to Develop a Prediction Tool for Lymph Node Spread and Survival in Mucoepidermoid Carcinoma of Salivary Gland Cancer

A Study on Building a Risk Prediction Model for Lymph Node Metastasis and a Nomogram for Overall Survival in Mucinous Sweat Gland Carcinoma Based on the SEER Database

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126568
Enrollment
Unknown
Registered
2026-06-11
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mucoepidermoid Carcinoma of Salivary Gland

Interventions

LNM Negative Group:None
Lymph Node Metastasis (LNM) Positive Group:None

Sponsors

Cancer Hospital of Shantou University Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Pathologically confirmed mucoepidermoid carcinoma; 2. The only primary malignant tumor; 3. Complete survival data.

Exclusion criteria

Exclusion criteria: 1. Patients with missing information on histological grade, stage, or TNM staging; 2. Patients with missing cervical lymph node information.

Design outcomes

Primary

MeasureTime frame
calibration;—

Secondary

MeasureTime frame
The model's discrimination;—

Countries

China

Contacts

Public ContactHanwei Peng

Cancer Hospital of Shantou University Medical College

penghanwei@126.com+86 137 2651 0488

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026